Inogen, Inc. (INGN)


-0.14 (-2.61%)
Symbol INGN
Price $5.22
Beta 0.986
Volume Avg. 0.28M
Market Cap 121.075M
Shares () -
52 Week Range 5.055-26.11
1y Target Est -
DCF Unlevered INGN DCF ->
DCF Levered INGN LDCF ->
ROE -31.98% Strong Sell
ROA -25.72% Sell
Operating Margin -
Debt / Equity 7.96% Neutral
P/E -1.23 Sell
P/B 0.44 Neutral


Consensus EPS

Upgrades & Downgrades

Latest INGN news

Mr. Nabil Shabshab
Medical Devices
NASDAQ Global Select

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.